[
  {
    "ts": null,
    "headline": "GE HealthCare announces 510(k) submission for CleaRecon DL technology designed to improve image quality in the interventional suite with AI-based reconstruction",
    "summary": "CHICAGO, December 03, 2024--GE HealthCare (Nasdaq: GEHC) announced today the 510(k) submission to the U.S. Food and Drug Administration for CleaRecon DL, deep learning technology, designed to improve the quality of cone-beam computed tomography (CBCT) images by bringing artificial intelligence (AI)-based 3D reconstruction to the interventional suite. This technology, which is pending 510(k) clearance, will be demonstrated at the Radiological Society of North America’s (RSNA) 2024 Annual Meeting",
    "url": "https://finnhub.io/api/news?id=f2371e0b90897561890c18ecb62bb3e8cd4922dafa81caa5d68ee602720973c3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733230800,
      "headline": "GE HealthCare announces 510(k) submission for CleaRecon DL technology designed to improve image quality in the interventional suite with AI-based reconstruction",
      "id": 131757058,
      "image": "https://s.yimg.com/ny/api/res/1.2/p9cJkLRrQOkvQZlDKKpgjA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD00MDk-/https://media.zenfs.com/en/business-wire.com/a82d7b1d7bc07441d9f3b9b203995853",
      "related": "GEHC",
      "source": "Yahoo",
      "summary": "CHICAGO, December 03, 2024--GE HealthCare (Nasdaq: GEHC) announced today the 510(k) submission to the U.S. Food and Drug Administration for CleaRecon DL, deep learning technology, designed to improve the quality of cone-beam computed tomography (CBCT) images by bringing artificial intelligence (AI)-based 3D reconstruction to the interventional suite. This technology, which is pending 510(k) clearance, will be demonstrated at the Radiological Society of North America’s (RSNA) 2024 Annual Meeting",
      "url": "https://finnhub.io/api/news?id=f2371e0b90897561890c18ecb62bb3e8cd4922dafa81caa5d68ee602720973c3"
    }
  },
  {
    "ts": null,
    "headline": "GE HealthCare: CleaRecon DL submitted for FDA approval",
    "summary": "GE HealthCare announces that it has submitted an application to the FDA to market CleaRecon DL, a deep learning technology aimed at improving the quality of cone-beam computed tomography images...",
    "url": "https://finnhub.io/api/news?id=f1b39dc17e42f88e1ffb1e6fdd20084daaaf2ba87cbeeb93db342933fe67fe69",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733218091,
      "headline": "GE HealthCare: CleaRecon DL submitted for FDA approval",
      "id": 131752977,
      "image": "",
      "related": "GEHC",
      "source": "Finnhub",
      "summary": "GE HealthCare announces that it has submitted an application to the FDA to market CleaRecon DL, a deep learning technology aimed at improving the quality of cone-beam computed tomography images...",
      "url": "https://finnhub.io/api/news?id=f1b39dc17e42f88e1ffb1e6fdd20084daaaf2ba87cbeeb93db342933fe67fe69"
    }
  }
]